News

Researchers at the Institute for Genome Sciences at the University of Maryland School of Medicine have been awarded a research program contract from the U.S. Food and Drug Administration (FDA) to sequence, assemble, and annotate a population of bacterial pathogens using two high-throughput sequencing (HTS) technologies in support of the expansion of a vetted public reference database.
| 2 min read

As the Earth’s human population marches toward 9 billion, the need for hardy new varieties of grain crops has never been greater.
| 2 min read

















